Endometrial stromal sarcoma of the uterus
Uterine sarcomas are rare tumors constituting 1–3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and ch...
Gespeichert in:
| Veröffentlicht in: | Anti-cancer drugs 1991-02, Vol.2 (1), p.35-38 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 38 |
|---|---|
| container_issue | 1 |
| container_start_page | 35 |
| container_title | Anti-cancer drugs |
| container_volume | 2 |
| creator | Meden, Harald Meyer-Rath, Dagmar Schauer, Alfred Kuhn, Walther |
| description | Uterine sarcomas are rare tumors constituting 1–3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and chemotherapy in the management of these tumors. We report a case of endometrial stromal sarcoma of the uterus in a 45-year-old woman. Total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy was performed, followed by adjuvant radiotherapy and tamoxifen treatment. The patient has now been seen regularly for 2 years from the start of the treatment and at present there is no evidence of disease. |
| doi_str_mv | 10.1097/00001813-199102000-00004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72497743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72497743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3554-2a6d53a2f87c390a88ecebb2dd2c4740651ae500a8aee0a90c16141fe869bddf3</originalsourceid><addsrcrecordid>eNp1kE9PAyEQxYnR1Fr9CCZ7MvGAwgILHE1T_yRNvOiZsDCbVtluhd00fnupW_Ukl4H33gyZH0IFJTeUaHlL8qGKMky1pqTML7yX-BGaUi4ZFpLTYzQlWmjMtWSn6Cylt5zIOpugCdVCKUGm6Hqx8V0LfVzbUKQ-du2-2ujypeiaol9BMfQQh3SOThobElwc6gy93i9e5o94-fzwNL9bYseE4Li0lRfMlo2SjmlilQIHdV16XzouOakEtSBINiwAsZo4WlFOG1CVrr1v2AxdjXO3sfsYIPWmXScHIdgNdEMysswLSc5yUI1BF7uUIjRmG9etjZ-GErOnZH4omV9K3xLPrZeHP4a6Bf_XOGLJPh_9XRfy8uk9DDuIZgU29CvzH3z2BWG-cRI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72497743</pqid></control><display><type>article</type><title>Endometrial stromal sarcoma of the uterus</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Meden, Harald ; Meyer-Rath, Dagmar ; Schauer, Alfred ; Kuhn, Walther</creator><creatorcontrib>Meden, Harald ; Meyer-Rath, Dagmar ; Schauer, Alfred ; Kuhn, Walther</creatorcontrib><description>Uterine sarcomas are rare tumors constituting 1–3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and chemotherapy in the management of these tumors. We report a case of endometrial stromal sarcoma of the uterus in a 45-year-old woman. Total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy was performed, followed by adjuvant radiotherapy and tamoxifen treatment. The patient has now been seen regularly for 2 years from the start of the treatment and at present there is no evidence of disease.</description><identifier>ISSN: 0959-4973</identifier><identifier>EISSN: 1473-5741</identifier><identifier>DOI: 10.1097/00001813-199102000-00004</identifier><identifier>PMID: 1958850</identifier><language>eng</language><publisher>England: Lippincott-Raven Publishers</publisher><subject>Antineoplastic Agents - therapeutic use ; Combined Modality Therapy ; Endometrial Neoplasms - pathology ; Endometrial Neoplasms - therapy ; Female ; Humans ; Hysterectomy ; Middle Aged ; Sarcoma - pathology ; Sarcoma - therapy ; Uterine Neoplasms - pathology ; Uterine Neoplasms - therapy</subject><ispartof>Anti-cancer drugs, 1991-02, Vol.2 (1), p.35-38</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3554-2a6d53a2f87c390a88ecebb2dd2c4740651ae500a8aee0a90c16141fe869bddf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1958850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meden, Harald</creatorcontrib><creatorcontrib>Meyer-Rath, Dagmar</creatorcontrib><creatorcontrib>Schauer, Alfred</creatorcontrib><creatorcontrib>Kuhn, Walther</creatorcontrib><title>Endometrial stromal sarcoma of the uterus</title><title>Anti-cancer drugs</title><addtitle>Anticancer Drugs</addtitle><description>Uterine sarcomas are rare tumors constituting 1–3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and chemotherapy in the management of these tumors. We report a case of endometrial stromal sarcoma of the uterus in a 45-year-old woman. Total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy was performed, followed by adjuvant radiotherapy and tamoxifen treatment. The patient has now been seen regularly for 2 years from the start of the treatment and at present there is no evidence of disease.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrial Neoplasms - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hysterectomy</subject><subject>Middle Aged</subject><subject>Sarcoma - pathology</subject><subject>Sarcoma - therapy</subject><subject>Uterine Neoplasms - pathology</subject><subject>Uterine Neoplasms - therapy</subject><issn>0959-4973</issn><issn>1473-5741</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE9PAyEQxYnR1Fr9CCZ7MvGAwgILHE1T_yRNvOiZsDCbVtluhd00fnupW_Ukl4H33gyZH0IFJTeUaHlL8qGKMky1pqTML7yX-BGaUi4ZFpLTYzQlWmjMtWSn6Cylt5zIOpugCdVCKUGm6Hqx8V0LfVzbUKQ-du2-2ujypeiaol9BMfQQh3SOThobElwc6gy93i9e5o94-fzwNL9bYseE4Li0lRfMlo2SjmlilQIHdV16XzouOakEtSBINiwAsZo4WlFOG1CVrr1v2AxdjXO3sfsYIPWmXScHIdgNdEMysswLSc5yUI1BF7uUIjRmG9etjZ-GErOnZH4omV9K3xLPrZeHP4a6Bf_XOGLJPh_9XRfy8uk9DDuIZgU29CvzH3z2BWG-cRI</recordid><startdate>199102</startdate><enddate>199102</enddate><creator>Meden, Harald</creator><creator>Meyer-Rath, Dagmar</creator><creator>Schauer, Alfred</creator><creator>Kuhn, Walther</creator><general>Lippincott-Raven Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199102</creationdate><title>Endometrial stromal sarcoma of the uterus</title><author>Meden, Harald ; Meyer-Rath, Dagmar ; Schauer, Alfred ; Kuhn, Walther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3554-2a6d53a2f87c390a88ecebb2dd2c4740651ae500a8aee0a90c16141fe869bddf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrial Neoplasms - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hysterectomy</topic><topic>Middle Aged</topic><topic>Sarcoma - pathology</topic><topic>Sarcoma - therapy</topic><topic>Uterine Neoplasms - pathology</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meden, Harald</creatorcontrib><creatorcontrib>Meyer-Rath, Dagmar</creatorcontrib><creatorcontrib>Schauer, Alfred</creatorcontrib><creatorcontrib>Kuhn, Walther</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anti-cancer drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meden, Harald</au><au>Meyer-Rath, Dagmar</au><au>Schauer, Alfred</au><au>Kuhn, Walther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endometrial stromal sarcoma of the uterus</atitle><jtitle>Anti-cancer drugs</jtitle><addtitle>Anticancer Drugs</addtitle><date>1991-02</date><risdate>1991</risdate><volume>2</volume><issue>1</issue><spage>35</spage><epage>38</epage><pages>35-38</pages><issn>0959-4973</issn><eissn>1473-5741</eissn><abstract>Uterine sarcomas are rare tumors constituting 1–3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and chemotherapy in the management of these tumors. We report a case of endometrial stromal sarcoma of the uterus in a 45-year-old woman. Total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy was performed, followed by adjuvant radiotherapy and tamoxifen treatment. The patient has now been seen regularly for 2 years from the start of the treatment and at present there is no evidence of disease.</abstract><cop>England</cop><pub>Lippincott-Raven Publishers</pub><pmid>1958850</pmid><doi>10.1097/00001813-199102000-00004</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-4973 |
| ispartof | Anti-cancer drugs, 1991-02, Vol.2 (1), p.35-38 |
| issn | 0959-4973 1473-5741 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72497743 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Antineoplastic Agents - therapeutic use Combined Modality Therapy Endometrial Neoplasms - pathology Endometrial Neoplasms - therapy Female Humans Hysterectomy Middle Aged Sarcoma - pathology Sarcoma - therapy Uterine Neoplasms - pathology Uterine Neoplasms - therapy |
| title | Endometrial stromal sarcoma of the uterus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A43%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endometrial%20stromal%20sarcoma%20of%20the%20uterus&rft.jtitle=Anti-cancer%20drugs&rft.au=Meden,%20Harald&rft.date=1991-02&rft.volume=2&rft.issue=1&rft.spage=35&rft.epage=38&rft.pages=35-38&rft.issn=0959-4973&rft.eissn=1473-5741&rft_id=info:doi/10.1097/00001813-199102000-00004&rft_dat=%3Cproquest_cross%3E72497743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72497743&rft_id=info:pmid/1958850&rfr_iscdi=true |